Clinical Trials Logo

Subarachnoid Haemorrhage clinical trials

View clinical trials related to Subarachnoid Haemorrhage.

Filter by:
  • None
  • Page 1

NCT ID: NCT02176174 Completed - Stroke Clinical Trials

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

Start date: December 2013
Phase: N/A
Study type: Observational

Specific cardiovascular diseases, such as stroke and heart attack, have been shown to vary by ethnic group. However, less is known about differences between ethnic groups and a wider range of cardiovascular diseases. This study will examine differences between ethnic groups (White, Black, South Asian and Mixed/Other) and first lifetime presentation of twelve different cardiovascular diseases. This information may help to predict the onset of cardiovascular diseases and inform disease prevention strategies. The hypothesis is that different ethnic groups have differing associations with the range of cardiovascular diseases studied.

NCT ID: NCT02062021 Active, not recruiting - Stroke Clinical Trials

Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease

Start date: January 2014
Phase: N/A
Study type: Observational

Autoimmune diseases are diseases in which inappropriate immune responses that have the capability of harming host cells play an important role. Evidence suggests that the presence of certain autoimmune diseases such as rheumatoid arthritis or systematic lupus erythematosus increase the risk of cardiovascular disease (CVD). However, this evidence is inconsistent for autoimmune disorders and no systematic approach has been previously used to study the relationship between a range of common autoimmune disorders and specific forms of cardiovascular diseases such as myocardial infarction, intracerebral and subarachnoid haemorrhage, or venous thrombosis. The investigators will use linked electronic health records to investigate whether commonly diagnosed autoimmune disorders are associated with increased risk of CVD development and whether effects differ in men and women and change with age.

NCT ID: NCT01947361 Active, not recruiting - Stroke Clinical Trials

Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)

Start date: January 2012
Phase: N/A
Study type: Observational

Study of heterogeneity in associations between heart rate and the initial presentation of 12 cardiovascular diseases.

NCT ID: NCT01937065 Active, not recruiting - Stroke Clinical Trials

Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study

IP4
Start date: January 2012
Phase: N/A
Study type: Observational

Study of heterogeneity in associations between social deprivation and the initial presentation of 12 cardiovascular diseases.

NCT ID: NCT01885507 Completed - Stroke Clinical Trials

Mechanical Ventilation in Brain-injured Patients

BI-VILI
Start date: July 2013
Phase: N/A
Study type: Observational

Protective ventilation (association of a tidal volume < 8 ml/kg with a positive end expiratory pressure) is poorly used in severe brain-injured patients. Moreover, a systematic approach to extubation may decrease the rate of extubation failure and enhance outcomes of brain-injured patients. We hypothesized that medical education and implementation of an evidence-base care bundle associating protective ventilation and systemic approach to extubation can reduce the duration of mechanical ventilation in brain-injured patients.

NCT ID: NCT01113645 Completed - Clinical trials for Infarction, Middle Cerebral Artery

Impact of Cranioplasty On Cerebral Perfusion

CCP
Start date: July 2010
Phase: N/A
Study type: Observational

The purpose of this study is to examine the impact of cranioplasty on cerebral hemodynamic and blood flow as prognostic factor in patients receiving decompressive craniectomy for Head injuries, Subarachnoid haemorrhage, intra-cerebral haemorrhage, cerebral dural sinus thrombosis, malignant middle cerebral artery stroke.

NCT ID: NCT00731627 Completed - Clinical trials for Subarachnoid Haemorrhage

Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial

STASH
Start date: January 2007
Phase: Phase 3
Study type: Interventional

Intracranial bleeding from ruptured blood vessels (called a subarachnoid haemorrhage -SAH) affects 7000 patients each year in the UK and is a source of considerable death and disability, even in young adults. Recent observations indicate that these bleeds can cause reduced cerebral blood flow which leads to a bad outcome. High rates of death and disability occur, and are particularly prevalent when low cerebral blood flow results in stroke. Prevention of cerebral artery spasm and improvement in blood vessel reflexes are the target of modern therapy. Candidate drugs include statins which have an impeccable safety record and multiple potential beneficial actions (improve cerebral blood flow, reduce inflammatory processes, reduce adverse blood coagulation) following SAH. The investigators plan to use a statin, Simvastatin (40 mg) to improve cerebral blood flow and reduce inflammation. We have already completed a phase 11 study (n=80) which demonstrated potential benefits for acute statin therapy following SAH, and the investigators now wish to conduct a multi-centre phase 111 study to explore any potential clinical benefits in a larger population (n=1600). The purpose is to see whether the positive effects of statins seen in our phase II study translate into clinical benefits - both short term (e.g. reduced need for intensive care) and long term (outcome and wellbeing at 6 months).